...
首页> 外文期刊>Journal of hypertension >The prevalence of concurrently raised blood glucose and blood pressure in India: a cross-sectional study of 2035 662 adults
【24h】

The prevalence of concurrently raised blood glucose and blood pressure in India: a cross-sectional study of 2035 662 adults

机译:印度同时升高的血糖和血压的患病率:2035 662名成人的横截面研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To inform integrated, person-centered interventions, this study aimed to determine the prevalence of having both a raised blood glucose and blood pressure (BP) in India, and its variation among states and population groups. Methods: We pooled data from three large household surveys (the Annual Health Survey, District Level Household and Facility Survey, and National Family Health Survey), which were carried out between 2012 and 2016 and included adults aged at least 15 years. Raised blood glucose was defined as having a plasma glucose reading at least 126 mg/dl if fasted and at least 200 mg/dl if not fasted, and raised BP as a SBP of at least 140 mmHg or DBP of at least 90 mmHg. The prevalence of having a concurrently raised blood glucose and BP (comorbid) was age-standardized to India's national population structure, and disaggregated by sex, age group, BMI group, rural-urban residency, household wealth quintile, education, state, and region. Results: The age-standardized prevalence of this comorbidity was 1.5% [95% confidence interval (CI), 1.5-1.5], and varied by a factor of 8.3 between states. Among those aged at least 50 years, 4.5% (95% CI, 4.3-4.7) with a BMI less than 23.0 kg/m(2) and 16.1% (95% CI, 15.0-17.4) with a BMI at least 30 kg/m(2) were comorbid. Age, BMI, household wealth quintile, male sex, and urban location were all positively associated with this comorbidity. Conclusion: A substantial proportion of India's population had both a raised blood glucose and BP, calling for integrated interventions to reduce cardiovascular disease risk. We identified large variation among states, age groups, and by rural-urban residency, which can inform health system planning and the targeting of interventions, such as appropriate screening programs, to those most in need.
机译:目的:通知综合,以人为本的干预措施,该研究旨在确定印度患有血糖和血压(BP)的患病率,以及各国和人口群体的变异。方法:我们汇集了来自三个大型家庭调查(年度健康调查,区级家庭和设施调查以及国家家庭健康调查)的数据,这些数据于2012年至2016年间在2012年至2016年间进行,并包括至少15年的成年人。升高的血糖定义为具有至少126mg / dL的血浆葡萄糖,如果禁食,至少200mg / dl,如果不禁食,并且升高为至少140mmHg或至少90mmHg的SBP。患有同伴血糖和BP(Comorbid)的患病率为印度的国家人口结构年龄标准化,并被性别,年龄组,BMI集团,农村城市居住,家庭财富,教育,州和地区分列。结果:该合并症的年龄标准化患病率为1.5%[95%置信区间(CI),1.5-1.5],各种尺寸变化。在至少50岁的人中,4.5%(95%CI,4.3-4.7),BMI小于23.0kg / m(2)和16.1%(95%CI,15.0-17.4),BMI至少30千克/ m(2)是合并的。年龄,BMI,家庭财富五分,男性和城市地区都与这种合并症相关。结论:印度大部分人口均具有升高的血糖和BP,呼吁综合干预措施来降低心血管疾病风险。我们确定了各国,年龄组和农村城市居留权之间的大量变化,可以向健康制度规划和适当的筛查计划的措施通知卫生系统规划和适当的筛选计划的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号